Biosimilars and Biologics is an open access journal from InnovationInfo publishing high-quality research, reviews and commentary in all areas of the biological sciences and Biosimilar. Research papers published by the journal represent significant advances bringing new biological insight to a specialized area of research. We also aim to provide a community forum for issues of importance to all biologists, regardless of sub-discipline.
The scope of the journal includes all of the basic biological, biomedical sciences and biopharmaceutical. Primary research published in Scholarly Journal of Biosimilars and Biologics includes novel experimental results, secondary data analysis and innovative experimental and computational methods. We also consider submissions from adjacent research fields where the central advance of the study is of interest to biologists, for example, chemical biology, biopharmaceuticals and biomedical engineering.
The submission and review processes are managed by our in-house professional editors supported by our Editorial Board Members, who provide technical expertise across the breadth of the life sciences. We are committed to rapid dissemination of important research results. Articles are published on a continuous basis with minimal time from acceptance to publication.
Biosimilars and Biologics is a novel peer-reviewed journal that runs using a single-masked and blinded policy whereby neither editor nor reviewer acknowledges the identification of the original author, and vice versa. The journal is also using the partial online system for quality in the peer-review process. Online submission and review system, where authors can submit manuscripts and track their progress. Reviewers can download manuscripts and submit their opinions. Editors can manage the whole submission, review, revise and publish process through the online system. Authors can manage the manuscripts are in which stage awaiting for publication. A 30-45 days’ rapid review process with international peer-review standards and with quality reviewers.
